News and Views


Nature Medicine 15, 488 - 490 (2009)
doi:10.1038/nm0509-488

Breaking the gene barrier in schizophrenia

Szatmár Horváth2 & Károly Mirnics1

  1. Károly Mirnics is in the Department of Psychiatry, Vanderbilt University, Nashville, Tennessee, USA.
  2. Szatmár Horváth is in the Department of Psychiatry, Vanderbilt University, Nashville, Tennessee, USA, and the Department of Psychiatry, University of Szeged, Szeged, Hungary.

Correspondence to: Károly Mirnics1 e-mail: karoly.mirnics@vanderbilt.edu


Studies of schizophrenia have been plagued by shortcomings such as weak genetic association with disease, inadequate animal models and limited replication of gene expression findings. Future success may lie not in overcoming any one of these limitations but in a broad approach strengthening the evidence in each area. Using such an approach, neuroscientists have uncovered a new gene behind the disease (pages 509–518).

Top


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.


Extra navigation

Subscribe to Nature Medicine

Subscribe

Open Innovation Challenges

naturejobs

ADVERTISEMENT